WinstonWınston
Back
Evonik Industries AG logo

Evonik Industries AG

EVKIF
45
Chemicals - Specialty · Basic Materials
Price
$21.52
+0.22 (+1.03%)
Market Cap
$10.03B
Exchange
Other OTC
Winston Score
45
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Strong
Stability
Mixed
Valuation
Good
Dividends
Exceptional

Winston Score History

The full picture

Evonik Industries is a German specialty chemicals company that makes ingredients and materials used in everyday products like cosmetics, animal feed, tires, and medicines. Its core products include amino acids (used in livestock nutrition), specialty additives for coatings and plastics, and active ingredients for pharmaceuticals and personal care. It is one of the largest specialty chemicals companies in the world and is majority-owned by a German public foundation.

Evonik earns money by selling specialty chemical products to industrial customers across sectors like agriculture, automotive, healthcare, and consumer goods. It operates globally, with a strong presence in Europe, North America, and Asia, generating roughly €15 billion in annual revenue. Its competitive edge comes from proprietary production processes and deep customer relationships, but the business faces ongoing pressure from high European energy costs and weak industrial demand, both of which squeeze margins and have kept returns on capital low in recent periods.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 466.0M (2021) → 466.0M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
24.7%
Thin — 24.7% gross margin
Profit after running costs
Operating Margin
12.4%
Healthy — 12.4% operating margin
Return on the money invested
ROCE
8.4%
Below par — 8.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-3.9%
Shrinking sales (-3.9% YoY)
Profit growth
EPS YoY
-71.6%
Earnings shrinking (-71.6% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
1346%
Turns 1346% of profit into real cash
Spare cash per sale
FCF Margin
6.0%
Thin free cash flow (6.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.57
Conservative — low debt load (0.57)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
83.2x
Expensive — P/E 83.2

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+72.0
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (83.2 → 11.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
5.59%
Healthy income — 5.59% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
+26.2%
Dividend growing fast (26.2% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial